PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study
The treatment of diseases that affect the central nervous system (CNS) represents a great research challenge due to the restriction imposed by the blood−brain barrier (BBB) to allow the passage of drugs into the brain. However, the use of modified nanomedicines engineered with different ligands that...
Saved in:
Main Authors: | Gina P. Hoyos-Ceballos (Author), Barbara Ruozi (Author), Ilaria Ottonelli (Author), Federica Da Ros (Author), Maria Angela Vandelli (Author), Flavio Forni (Author), Eleonora Daini (Author), Antonietta Vilella (Author), Michele Zoli (Author), Giovanni Tosi (Author), Jason T. Duskey (Author), Betty L. López-Osorio (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles
by: Antonietta Vilella, et al.
Published: (2015) -
Nanomedicine Against Aβ Aggregation by β-Sheet Breaker Peptide Delivery: In Vitro Evidence
by: Francesca Pederzoli, et al.
Published: (2019) -
Corrigendum to "Quantitative comparison of the protein corona of nanoparticles with different matrices" [Int J Pharm X 2022 Oct 21;4: 100136]
by: Ilaria Ottonelli, et al.
Published: (2023) -
Quantitative comparison of the protein corona of nanoparticles with different matrices
by: Ilaria Ottonelli, et al.
Published: (2022) -
Assessment of the Effect of PLGA Co-polymers and PEG on the Formation and Characteristics of PLGA-PEG-PLGA Co-block Polymer Using Statistical Approach
by: Teuku Nanda Saifullah Sulaiman, et al.
Published: (2019)